SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001213900-23-079563
Filing Date
2023-09-26
Accepted
2023-09-26 16:14:18
Documents
2
Period of Report
2023-09-22

Document Format Files

Seq Description Document Type Size
1 ownership.html 3  
1 ownership.xml 3 1599
2 POWER OF ATTORNEY ea185814ex-24_jasper.htm EX-24 6915
  Complete submission text file 0001213900-23-079563.txt   9936
Mailing Address 3061 ZANKER RD SAN JOSE CA 95134
Business Address
CROSS HERB (Reporting) CIK: 0001230721 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-39138 | Film No.: 231280608

Mailing Address 2200 BRIDGE PKWY SUITE #102 REDWOOD CITY CA 94065
Business Address 2200 BRIDGE PKWY SUITE #102 REDWOOD CITY CA 94065 6505491400
Jasper Therapeutics, Inc. (Issuer) CIK: 0001788028 (see all company filings)

IRS No.: 842984849 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)